Apalutamide 60mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 60mg
Reference Brands: ERLEADA (USA/EU)
Category: Oncology Cancer Care
Apalutamide is a next-generation androgen receptor inhibitor used for the treatment of prostate cancer, including non-metastatic castration-resistant and metastatic castration-sensitive forms. It works by blocking the effects of androgens, hormones that promote the growth of prostate cancer cells. Administered orally, Apalutamide is often used in combination with androgen deprivation therapy (ADT). Erleada has become an important option in prolonging survival and delaying disease progression in prostate cancer patients.
Apalutamide — third party manufacturing & bulk supply
Apalutamide 60mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Apalutamide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Apalutamide →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Apalutamide is used for the treatment of prostate cancer, including non-metastatic castration-resistant and metastatic castration-sensitive prostate cancer. It works by blocking androgen receptors, which prevents testosterone from stimulating the growth of cancer cells, helping to slow disease progression and improve patient outcomes.
Apalutamide is made from Apalutamide, a next-generation androgen receptor inhibitor that selectively binds to androgen receptors in prostate cancer cells to inhibit their activity.
The trade name of Apalutamide is Erleada.
Apalutamide (Erleada) is manufactured by Janssen Biotech, a division of Johnson & Johnson, and distributed globally under approved regulatory pathways.
The generic name of Apalutamide is Apalutamide.
The brand name of Apalutamide is Erleada.
Apalutamide is manufactured in the United States and Europe by Janssen Biotech under GMP-certified facilities.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
